Juliette S.
- Country
- France
- Department
- Unité 502
Research Overview
- Efficacy of Rituximab Versus Placebo in Anti-MAG Neuropathy Patients with Predicted Good Response: A Randomized Controlled Trial
- Efficacy and Safety of Nipocalimab in Adults with Chronic Inflammatory Demyelinating Polyneuropathy: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 15 of 103 partner sites.
Specializations
Autoimmune Neurological Disorders
The investigator specializes in treating complex neurological conditions, with particular emphasis on anti-MAG neuropathy and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
- Autoimmune Neuropathies
- Demyelinating Disorders
- Neurological Disability Management
Current therapeutic interests include novel antibody-based treatments and targeted immunotherapy approaches for neurological disorders.
Immunotherapy Innovation
The investigator focuses on advancing treatment options in neuroimmunology, particularly examining the therapeutic potential of rituximab and nipocalimab in treating autoimmune neurological conditions.
- Targeted Antibody Therapies
- Immunological Response Assessment
- Treatment Optimization Strategies
Areas of expertise include evaluating treatment responses and developing targeted therapeutic approaches for autoimmune neuropathies.
Clinical Outcomes Research
The investigator specializes in evaluating neurological disability outcomes using advanced assessment tools such as the I-RODS score and monitoring disease progression in chronic neurological conditions.
- Disability Assessment Methods
- Treatment Response Evaluation
- Long-term Outcome Monitoring
Expertise includes developing and implementing clinical assessment protocols for neurological disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.